Video - Post-transplant lymphoproliferative disorders (NORD)
test
00:00 / 00:00
More Videos
07:05
Isolated primary immunoglobulin M deficiency
07:36
Selective immunoglobulin A deficiency
05:15
X-linked agammaglobulinemia
05:37
Adenosine deaminase deficiency
06:20
Ataxia-telangiectasia
08:03
Hyper IgM syndrome
08:52
Wiskott-Aldrich syndrome
07:21
Complement deficiency
06:57
Chronic granulomatous disease
06:56
Leukocyte adhesion deficiency
05:05
DiGeorge syndrome
07:53
Thymic aplasia
Video Summary
Post-transplant lymphoproliferative disorders (PTLDs) are a group of lymphoid neoplasms characterized by uncontrolled growths of lymphocytes. It occurs after someone has received a solid organ or stem cell transplant that requires immunosuppressive medications to prevent transplant rejection. PTLDs are caused by Epstein-Barr virus (EBV) infection and can originate in either type of lymphocyte: B-cells or T-cells. Diagnosis involves blood tests, a biopsy, and imaging, while treatment may include surgery, chemotherapy, and radiation.